We are live on ! Find out more
ENZY

Enzymotec Ltd
ENZY

Delisted

ENZY was delisted on the 10th of January, 2018.

Back to rankings

34 hedge funds and large institutions have $187M invested in Enzymotec Ltd in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

72% more capital invested

Capital invested by funds: $109M → $187M (+$78.5M)

48% more funds holding

Funds holding: 23 → 34 (+11)

Holders
34
Holders Change
+11
Holders Change %
+47.83%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
12
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$67.3M
2
VAM
Visium Asset Management
New York
+$11.9M
3
Millennium Management
Millennium Management
New York
+$9.86M
4
AP
Alydar Partners
Massachusetts
+$5.87M
5
PA
Perceptive Advisors
New York
+$5.68M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$14M
2
Goldman Sachs
Goldman Sachs
New York
-$351K
3
BIT
BlackRock Institutional Trust
California
-$327K
4
PCM
Prelude Capital Management
New York
-$270K
5
U
UBS
Switzerland
-$185K

ENZY Hedge Fund Activity: Q1 2014 in Review

34 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q1 2014, worth a combined $187M — up 72% from $109M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ENZY positions and 3 closed out — a net gain of 11 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Paulson & Co, adding an estimated $67.3M. The largest seller was Fidelity Investments, exiting entirely with an estimated $14M sold.

  • 34 institutional investors held Enzymotec Ltd (ENZY) as of Q1 2014, up from 23 in Q4 2013.
  • Funds reported $187M of Enzymotec Ltd stock for Q1 2014, up 72% quarter-over-quarter.
  • 14 funds opened new Enzymotec Ltd positions in Q1 2014 and 3 closed out, a net change of +11 holders.
  • The largest Enzymotec Ltd buyer in Q1 2014 was Paulson & Co, an estimated $67.3M added.
  • The largest Enzymotec Ltd seller in Q1 2014 was Fidelity Investments, an estimated $14M sold.

Based on aggregated 13F filings for Q1 2014.